These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15265273)

  • 1. Increased homocysteine and decreased adenosine formation in Alzheimer's disease.
    Selley ML
    Neurol Res; 2004 Jul; 26(5):554-7. PubMed ID: 15265273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease.
    Selley ML
    Neurobiol Aging; 2007 Dec; 28(12):1834-9. PubMed ID: 16996649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease.
    Selley ML; Close DR; Stern SE
    Neurobiol Aging; 2002; 23(3):383-8. PubMed ID: 11959400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
    Oulhaj A; Refsum H; Beaumont H; Williams J; King E; Jacoby R; Smith AD
    Int J Geriatr Psychiatry; 2010 Jan; 25(1):82-90. PubMed ID: 19484711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
    Hernanz A; De la Fuente M; Navarro M; Frank A
    Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma homocysteine levels are not increased in murine models of Alzheimer's disease.
    Santiard-Baron D; Aupetit J; Janel N
    Neurosci Res; 2005 Dec; 53(4):447-9. PubMed ID: 16213620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma homocysteine in Alzheimer's disease with or without co-morbid depressive symptoms.
    Kitzlerová E; Fisar Z; Jirák R; Zvĕrová M; Hroudová J; Benaková H; Raboch J
    Neuro Endocrinol Lett; 2014; 35(1):42-9. PubMed ID: 24625917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma levels of endogenous hydrogen sulfide and homocysteine in patients with Alzheimer's disease and vascular dementia and the significance thereof].
    Liu XQ; Liu XQ; Jiang P; Huang H; Yan Y
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2246-9. PubMed ID: 19087670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S-adenosylhomocysteine: a better marker of the development of Alzheimer's disease than homocysteine?
    Chang PY; Lu SC; Chen CH
    J Alzheimers Dis; 2010; 21(1):65-6. PubMed ID: 20413857
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients.
    Morillas-Ruiz JM; Rubio-Perez JM; Albaladejo MD; Zafrilla P; Parra S; Vidal-Guevara ML
    J Neurol Sci; 2010 Dec; 299(1-2):175-8. PubMed ID: 20850133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-inflammatory cytokines IL-1β and TNF-α are not associated with plasma homocysteine concentration in Alzheimer's disease.
    Veryard L; Jones E; Weaving G; Smith E; Cheek L; Wickramasinghe A; Tabet N
    Curr Alzheimer Res; 2013 Feb; 10(2):174-9. PubMed ID: 23463936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced soluble CD40 ligand and Alzheimer's disease: evidence of a possible pathogenetic role.
    Desideri G; Cipollone F; Necozione S; Marini C; Lechiara MC; Taglieri G; Zuliani G; Fellin R; Mezzetti A; di Orio F; Ferri C
    Neurobiol Aging; 2008 Mar; 29(3):348-56. PubMed ID: 17123665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual effect of DL-homocysteine and S-adenosylhomocysteine on brain synthesis of the glutamate receptor antagonist, kynurenic acid.
    Luchowska E; Luchowski P; Paczek R; Ziembowicz A; Kocki T; Turski WA; Wielosz M; Lazarewicz J; Urbanska EM
    J Neurosci Res; 2005 Feb; 79(3):375-82. PubMed ID: 15605380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer's disease.
    Arlt S; Schwedhelm E; Kölsch H; Jahn H; Linnebank M; Smulders Y; Jessen F; Böger RH; Popp J
    J Alzheimers Dis; 2012; 31(4):751-8. PubMed ID: 22710910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of vascular risk, systemic inflammation, and microvascular pathology and neuropsychiatric symptoms in Alzheimer's disease.
    Hall JR; Wiechmann AR; Johnson LA; Edwards M; Barber RC; Winter AS; Singh M; O'Bryant SE
    J Alzheimers Dis; 2013; 35(2):363-71. PubMed ID: 23403534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical studies of hyperhomocysteinemia and Alzheimer's disease].
    Li YL; Hou Y; Niu C; Yu LX; Cheng YY; Hong Y
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 Mar; 29(2):116-8, 127. PubMed ID: 23833960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine and Alzheimer's disease.
    Miller JW
    Nutr Rev; 1999 Apr; 57(4):126-9. PubMed ID: 10228350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma homocysteine level and apathy in Alzheimer's disease.
    Chen CS; Yeh YC; Chang YS; Huang MF
    J Am Geriatr Soc; 2011 Sep; 59(9):1752-4. PubMed ID: 22136538
    [No Abstract]   [Full Text] [Related]  

  • 19. [Homocysteine and Alzheimer's disease].
    Qin Y; Qi JS; Qiao JT
    Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):66-9. PubMed ID: 15127604
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on homocysteine plasma levels in Alzheimer's patients. Relevance for neurodegeneration.
    Agnati LF; Genedani S; Rasio G; Galantucci M; Saltini S; Filaferro M; Franco R; Mora F; Ferré S; Fuxe K
    J Neural Transm (Vienna); 2005 Jan; 112(1):163-9. PubMed ID: 15599614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.